Results 211 to 220 of about 296,364 (264)
L-Arginine-Modified Chitosan Curcumin Nanocrystals Target M1 Macrophages via CAT-2/Clathrin-Mediated Endocytosis for Mitochondrial Protection and ALI/ARDS Therapy. [PDF]
PharmaceuticsYang X, Wu S, Dou Z, Dong Y, Dai J.
europepmc +1 more source
Comprehensive analysis of intestinal barrier function and microbial diversity changes in L-arginine-induced acute pancreatitis mice. [PDF]
Eur J Med ResZhang P +4 more
europepmc +1 more source
L-Arginine Supplementation Improves Endurance Under Chronic Fatigue: Inducing In Vivo Paradigms with In Vitro Support. [PDF]
NutrientsLee S +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratio
Pharmacology & Therapeutics, 2007Cardiovascular diseases (CVD) are still the most frequent cause of death in Western Europe. Pathophysiological experiments revealed in the last years that the vascular endothelium, as well as a result of the synthesis of nitric oxide (NO), is a crucial regulator of vascular function and homeostasis.
Stefanie M, Bode-Böger +2 more
openaire +2 more sources
L-Arginine as an Antihypertensive Agent
Journal of Cardiovascular Pharmacology, 1992L-Arginine, the precursor of endothelium-derived relaxing factor (EDRF)/nitric oxide (NO), was administered intravenously in five patients with essential hypertension, one with renovascular hypertension, one with primary aldosteronism, and one with Cushing's syndrome. During the administration, the mean arterial pressure decreased concomitantly with an
K, Hishikawa +4 more
openaire +2 more sources
The Clinical Pharmacology of L-Arginine
Annual Review of Pharmacology and Toxicology, 2001L-Arginine (2-amino-5-guanidinovaleric acid) is the precursor of nitric oxide, an endogenous messenger molecule involved in a variety of endothelium-mediated physiological effects in the vascular system. Acute and chronic administration of L-arginine has been shown to improve endothelial function in animal models of hypercholesterolemia and ...
R H, Böger, S M, Bode-Böger
openaire +2 more sources
The crystal structure of l-arginine
Chemical Communications, 2012We report the crystal structure of L-arginine, one of the last remaining natural amino acids for which the crystal structure has never been determined; structure determination was carried out directly from powder X-ray diffraction (XRD) data, exploiting the direct-space genetic algorithm technique for structure solution followed by Rietveld refinement.
Emilie, Courvoisier +4 more
openaire +2 more sources
Cardiovascular effect of L-arginine
Current Opinion in Nephrology and Hypertension, 1998Most of the known cardiovascular effects of L-arginine are exerted via its conversion to nitric oxide by nitric oxide synthase. Accumulating evidence indicates that supplemental administration of L-arginine is sufficient to restore endothelium-derived nitric oxide production in many disorders in which endothelium-derived nitric oxide production is ...
A J, Maxwell, J P, Cooke
openaire +2 more sources
Bacterial electrode for l-arginine
Talanta, 1982Streptococcus lactis bacterial cells are employed for the conversion of L-arginine into ammonia. An ammonia gas-electrode is used as a detector. The combination of bacterial action and the gas electrode responds linearly to L-arginine over the concentration range 8.0 x 10(-6) - 1.0 x 10(-3)M, with a slope of 59.0 mV/decade and is selective with respect
S R, Grobler, N, Basson, C W, Van Wyk
openaire +2 more sources
Mitochondrion, 2007
We investigated the endothelial function in MELAS patients and also evaluated the therapeutic effects of L-arginine. Concentrations of L-arginine during the acute phase of MELAS were significantly lower than in control subjects. L-arginine infusions significantly improved all symptoms suggesting stroke within 30 min, and oral administration ...
Yasutoshi, Koga +6 more
openaire +2 more sources
We investigated the endothelial function in MELAS patients and also evaluated the therapeutic effects of L-arginine. Concentrations of L-arginine during the acute phase of MELAS were significantly lower than in control subjects. L-arginine infusions significantly improved all symptoms suggesting stroke within 30 min, and oral administration ...
Yasutoshi, Koga +6 more
openaire +2 more sources